HIV is the abbreviation for the human immunodeficiency virus. This disease is one of the most serious infectious diseases as it has caused immense devastation worldwide. According to the United Nations Program on HIV/AIDS (UNAIDS), there are almost 37 million people currently living with HIV worldwide, leading to an estimated number of 690,000 deaths from HIV-related causes in 2018.
Effects of HIV
When HIV enters the body, it breaks down the immune system by attacking and killing CD4 cells, which are a type of white blood cell. This can cause acquired immune deficiency syndrome (AIDS), which is the most advanced stage of the disease. AIDS is characterized by the body’s inability to fight off infections and other diseases, eventually leading to severe complications or death.
Although there is, unfortunately, no cure for HIV/AIDS, there is available treatment. This is normally a combination of antiretroviral drugs that work by preventing HIV from reproducing, and so keeping the virus at a low count. They can also be used to reduce the risk of transmitting the virus to another person. These drugs are highly effective when taken correctly, leading to a longer and healthier life for those with HIV. They also reduce the risk of transmitting the virus to others by up to 96%.
Improving the chances of survival
The World Health Organization (WHO) recommends that all people with HIV receive treatment, regardless of their CD4 count. They recommend that treatment should be started as soon as possible after diagnosis, as it greatly increases the chances of survival and reduces AIDS-related complications.
Finding a long-term cure
However, there are still many people living with HIV who do not have access to antiviral drugs. In addition to this, even those who do have access to treatment may not take their medicines correctly or suffer from drug resistance. These issues need to be addressed if the goal of finding a cure is to be reached. For example, organizations like UNAIDS are working to make HIV-related drugs more affordable and accessible to those in need.
Viraday Tablet is a combination of three drugs, efavirenz, emtricitabine, and tenofovir disoproxil fumarate, that are used together to slow down the replication of HIV (human immunodeficiency virus). HIV is a virus that attacks and destroys the body’s immune system, making it difficult for the body to fight off infections and other diseases.
Effective action from this medicine
Viraday Tablet is a prescription drug used to treat HIV infection in adults. It is taken once a day and is available as either a tablet or as an oral solution. This medication works by blocking the action of a specific enzyme in the virus, which is necessary for it to reproduce. Viraday tablet is often used alongside other antiretroviral medications in order to lower the amount of virus in the body and prevent further damage to the immune system. It is important to note that while this drug is effective in treating HIV, it will not cure it.
Effects to be taken with precaution
Another key feature of the Viraday Tablet is that it is not associated with as many side effects compared to older HIV medications. The main side effects reported include fatigue, headaches, dizziness, abdominal pain, and nausea. These side effects typically decrease after the first few weeks of treatment. Additionally, Viraday Tablet may interact with other medications and supplements, so it’s important to check with your healthcare provider for potential interactions.
The addition of Viraday Tablet to the world of HIV medications has been revolutionary for those living with the virus. This medication helps fight the virus on multiple fronts, decreases the risk of developing resistance to the drugs, and is associated with fewer side effects than some of the other HIV medications. Despite the fact that Viraday Tablet cannot cure HIV, it can still help infected individuals better manage the disease and improve their overall quality of life.
Conclusion
In conclusion, HIV is a serious disease with no known cure. However, antiretroviral drugs are available and can significantly reduce the risk of death and transmission, as well as improve quality of life. If drug access and adherence are improved, then we may one day be closer to finding a cure.
